line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,BHAGCHEM.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,BHAGCHEM.NS
Normalized EBITDA,2025-03-31 00:00:00,462266000.0,BHAGCHEM.NS
Total Unusual Items,2025-03-31 00:00:00,0.0,BHAGCHEM.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Reconciled Depreciation,2025-03-31 00:00:00,138639000.0,BHAGCHEM.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,2781287000.0,BHAGCHEM.NS
EBITDA,2025-03-31 00:00:00,462266000.0,BHAGCHEM.NS
EBIT,2025-03-31 00:00:00,323627000.0,BHAGCHEM.NS
Net Interest Income,2025-03-31 00:00:00,-71131000.0,BHAGCHEM.NS
Interest Expense,2025-03-31 00:00:00,71131000.0,BHAGCHEM.NS
Interest Income,2025-03-31 00:00:00,,BHAGCHEM.NS
Normalized Income,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Total Expenses,2025-03-31 00:00:00,4173895000.0,BHAGCHEM.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,BHAGCHEM.NS
Diluted Average Shares,2025-03-31 00:00:00,121555263.0,BHAGCHEM.NS
Basic Average Shares,2025-03-31 00:00:00,121555263.0,BHAGCHEM.NS
Diluted EPS,2025-03-31 00:00:00,1.14,BHAGCHEM.NS
Basic EPS,2025-03-31 00:00:00,1.14,BHAGCHEM.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Net Income Common Stockholders,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Net Income Continuous Operations,2025-03-31 00:00:00,138573000.0,BHAGCHEM.NS
Tax Provision,2025-03-31 00:00:00,113923000.0,BHAGCHEM.NS
Pretax Income,2025-03-31 00:00:00,252496000.0,BHAGCHEM.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,92781000.0,BHAGCHEM.NS
Special Income Charges,2025-03-31 00:00:00,0.0,BHAGCHEM.NS
Other Special Charges,2025-03-31 00:00:00,,BHAGCHEM.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-71131000.0,BHAGCHEM.NS
Total Other Finance Cost,2025-03-31 00:00:00,,BHAGCHEM.NS
Interest Expense Non Operating,2025-03-31 00:00:00,71131000.0,BHAGCHEM.NS
Interest Income Non Operating,2025-03-31 00:00:00,,BHAGCHEM.NS
Operating Income,2025-03-31 00:00:00,230846000.0,BHAGCHEM.NS
Operating Expense,2025-03-31 00:00:00,1392608000.0,BHAGCHEM.NS
Other Operating Expenses,2025-03-31 00:00:00,847138000.0,BHAGCHEM.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,138639000.0,BHAGCHEM.NS
Amortization,2025-03-31 00:00:00,,BHAGCHEM.NS
Depreciation Income Statement,2025-03-31 00:00:00,138639000.0,BHAGCHEM.NS
Research And Development,2025-03-31 00:00:00,,BHAGCHEM.NS
Selling General And Administration,2025-03-31 00:00:00,,BHAGCHEM.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,BHAGCHEM.NS
General And Administrative Expense,2025-03-31 00:00:00,,BHAGCHEM.NS
Rent And Landing Fees,2025-03-31 00:00:00,,BHAGCHEM.NS
Gross Profit,2025-03-31 00:00:00,1623454000.0,BHAGCHEM.NS
Cost Of Revenue,2025-03-31 00:00:00,2781287000.0,BHAGCHEM.NS
Total Revenue,2025-03-31 00:00:00,4404741000.0,BHAGCHEM.NS
Operating Revenue,2025-03-31 00:00:00,4404741000.0,BHAGCHEM.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,BHAGCHEM.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.323183,BHAGCHEM.NS
Normalized EBITDA,2024-03-31 00:00:00,455915000.0,BHAGCHEM.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,BHAGCHEM.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Reconciled Depreciation,2024-03-31 00:00:00,109799000.0,BHAGCHEM.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,2466226000.0,BHAGCHEM.NS
EBITDA,2024-03-31 00:00:00,455915000.0,BHAGCHEM.NS
EBIT,2024-03-31 00:00:00,346116000.0,BHAGCHEM.NS
Net Interest Income,2024-03-31 00:00:00,-76894000.0,BHAGCHEM.NS
Interest Expense,2024-03-31 00:00:00,76894000.0,BHAGCHEM.NS
Interest Income,2024-03-31 00:00:00,8360000.0,BHAGCHEM.NS
Normalized Income,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Total Expenses,2024-03-31 00:00:00,3757149000.0,BHAGCHEM.NS
Rent Expense Supplemental,2024-03-31 00:00:00,3750000.0,BHAGCHEM.NS
Diluted Average Shares,2024-03-31 00:00:00,113176398.0,BHAGCHEM.NS
Basic Average Shares,2024-03-31 00:00:00,104122286.0,BHAGCHEM.NS
Diluted EPS,2024-03-31 00:00:00,1.61,BHAGCHEM.NS
Basic EPS,2024-03-31 00:00:00,1.75,BHAGCHEM.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Net Income Common Stockholders,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Net Income Continuous Operations,2024-03-31 00:00:00,182214000.0,BHAGCHEM.NS
Tax Provision,2024-03-31 00:00:00,87008000.0,BHAGCHEM.NS
Pretax Income,2024-03-31 00:00:00,269222000.0,BHAGCHEM.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,26783000.0,BHAGCHEM.NS
Special Income Charges,2024-03-31 00:00:00,0.0,BHAGCHEM.NS
Other Special Charges,2024-03-31 00:00:00,,BHAGCHEM.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-76894000.0,BHAGCHEM.NS
Total Other Finance Cost,2024-03-31 00:00:00,24155000.0,BHAGCHEM.NS
Interest Expense Non Operating,2024-03-31 00:00:00,76894000.0,BHAGCHEM.NS
Interest Income Non Operating,2024-03-31 00:00:00,8360000.0,BHAGCHEM.NS
Operating Income,2024-03-31 00:00:00,319333000.0,BHAGCHEM.NS
Operating Expense,2024-03-31 00:00:00,1290923000.0,BHAGCHEM.NS
Other Operating Expenses,2024-03-31 00:00:00,848322000.0,BHAGCHEM.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,109799000.0,BHAGCHEM.NS
Amortization,2024-03-31 00:00:00,1340000.0,BHAGCHEM.NS
Depreciation Income Statement,2024-03-31 00:00:00,109799000.0,BHAGCHEM.NS
Research And Development,2024-03-31 00:00:00,25090000.0,BHAGCHEM.NS
Selling General And Administration,2024-03-31 00:00:00,117521000.0,BHAGCHEM.NS
Selling And Marketing Expense,2024-03-31 00:00:00,53086000.0,BHAGCHEM.NS
General And Administrative Expense,2024-03-31 00:00:00,64435000.0,BHAGCHEM.NS
Rent And Landing Fees,2024-03-31 00:00:00,3750000.0,BHAGCHEM.NS
Gross Profit,2024-03-31 00:00:00,1610256000.0,BHAGCHEM.NS
Cost Of Revenue,2024-03-31 00:00:00,2466226000.0,BHAGCHEM.NS
Total Revenue,2024-03-31 00:00:00,4076482000.0,BHAGCHEM.NS
Operating Revenue,2024-03-31 00:00:00,4076482000.0,BHAGCHEM.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,BHAGCHEM.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.292107,BHAGCHEM.NS
Normalized EBITDA,2023-03-31 00:00:00,760204000.0,BHAGCHEM.NS
Total Unusual Items,2023-03-31 00:00:00,0.0,BHAGCHEM.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Reconciled Depreciation,2023-03-31 00:00:00,98079000.0,BHAGCHEM.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,3813153000.0,BHAGCHEM.NS
EBITDA,2023-03-31 00:00:00,760204000.0,BHAGCHEM.NS
EBIT,2023-03-31 00:00:00,662125000.0,BHAGCHEM.NS
Net Interest Income,2023-03-31 00:00:00,-46467000.0,BHAGCHEM.NS
Interest Expense,2023-03-31 00:00:00,24294000.0,BHAGCHEM.NS
Interest Income,2023-03-31 00:00:00,3465000.0,BHAGCHEM.NS
Normalized Income,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Total Expenses,2023-03-31 00:00:00,4343289000.0,BHAGCHEM.NS
Rent Expense Supplemental,2023-03-31 00:00:00,3750000.0,BHAGCHEM.NS
Diluted Average Shares,2023-03-31 00:00:00,1018155000.0,BHAGCHEM.NS
Basic Average Shares,2023-03-31 00:00:00,1018155000.0,BHAGCHEM.NS
Diluted EPS,2023-03-31 00:00:00,0.443,BHAGCHEM.NS
Basic EPS,2023-03-31 00:00:00,0.443,BHAGCHEM.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Net Income Common Stockholders,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Net Income Continuous Operations,2023-03-31 00:00:00,451516000.0,BHAGCHEM.NS
Tax Provision,2023-03-31 00:00:00,186315000.0,BHAGCHEM.NS
Pretax Income,2023-03-31 00:00:00,637831000.0,BHAGCHEM.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,1795000.0,BHAGCHEM.NS
Special Income Charges,2023-03-31 00:00:00,0.0,BHAGCHEM.NS
Other Special Charges,2023-03-31 00:00:00,,BHAGCHEM.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-46467000.0,BHAGCHEM.NS
Total Other Finance Cost,2023-03-31 00:00:00,25638000.0,BHAGCHEM.NS
Interest Expense Non Operating,2023-03-31 00:00:00,24294000.0,BHAGCHEM.NS
Interest Income Non Operating,2023-03-31 00:00:00,3465000.0,BHAGCHEM.NS
Operating Income,2023-03-31 00:00:00,676701000.0,BHAGCHEM.NS
Operating Expense,2023-03-31 00:00:00,530136000.0,BHAGCHEM.NS
Other Operating Expenses,2023-03-31 00:00:00,10441000.0,BHAGCHEM.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,98079000.0,BHAGCHEM.NS
Amortization,2023-03-31 00:00:00,1062000.0,BHAGCHEM.NS
Depreciation Income Statement,2023-03-31 00:00:00,97017000.0,BHAGCHEM.NS
Research And Development,2023-03-31 00:00:00,15984000.0,BHAGCHEM.NS
Selling General And Administration,2023-03-31 00:00:00,108635000.0,BHAGCHEM.NS
Selling And Marketing Expense,2023-03-31 00:00:00,53432000.0,BHAGCHEM.NS
General And Administrative Expense,2023-03-31 00:00:00,55203000.0,BHAGCHEM.NS
Rent And Landing Fees,2023-03-31 00:00:00,3750000.0,BHAGCHEM.NS
Gross Profit,2023-03-31 00:00:00,1206837000.0,BHAGCHEM.NS
Cost Of Revenue,2023-03-31 00:00:00,3813153000.0,BHAGCHEM.NS
Total Revenue,2023-03-31 00:00:00,5019990000.0,BHAGCHEM.NS
Operating Revenue,2023-03-31 00:00:00,5019990000.0,BHAGCHEM.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,0.0,BHAGCHEM.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.303276,BHAGCHEM.NS
Normalized EBITDA,2022-03-31 00:00:00,652342000.0,BHAGCHEM.NS
Total Unusual Items,2022-03-31 00:00:00,0.0,BHAGCHEM.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,357478000.0,BHAGCHEM.NS
Reconciled Depreciation,2022-03-31 00:00:00,87304000.0,BHAGCHEM.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,3315619000.0,BHAGCHEM.NS
EBITDA,2022-03-31 00:00:00,652342000.0,BHAGCHEM.NS
EBIT,2022-03-31 00:00:00,565038000.0,BHAGCHEM.NS
Net Interest Income,2022-03-31 00:00:00,-88216000.0,BHAGCHEM.NS
Interest Expense,2022-03-31 00:00:00,51955000.0,BHAGCHEM.NS
Interest Income,2022-03-31 00:00:00,2663000.0,BHAGCHEM.NS
Normalized Income,2022-03-31 00:00:00,357478000.0,BHAGCHEM.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,357478000.0,BHAGCHEM.NS
Total Expenses,2022-03-31 00:00:00,3748728000.0,BHAGCHEM.NS
Rent Expense Supplemental,2022-03-31 00:00:00,3470000.0,BHAGCHEM.NS
Diluted Average Shares,2022-03-31 00:00:00,95513793.0,BHAGCHEM.NS
Basic Average Shares,2022-03-31 00:00:00,95513793.0,BHAGCHEM.NS
Diluted EPS,2022-03-31 00:00:00,3.74274,BHAGCHEM.NS
Basic EPS,2022-03-31 00:00:00,3.74274,BHAGCHEM.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,357478000.0,BHAGCHEM.NS
Net Income Common Stockholders,2022-03-31 00:00:00,357478000.0,BHAGCHEM.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,BHAGCHEM.NS
Net Income,2022-03-31 00:00:00,357478000.0,BHAGCHEM.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,357477000.0,BHAGCHEM.NS
Net Income Continuous Operations,2022-03-31 00:00:00,357477000.0,BHAGCHEM.NS
Tax Provision,2022-03-31 00:00:00,155606000.0,BHAGCHEM.NS
Pretax Income,2022-03-31 00:00:00,513083000.0,BHAGCHEM.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,2919000.0,BHAGCHEM.NS
Special Income Charges,2022-03-31 00:00:00,0.0,BHAGCHEM.NS
Other Special Charges,2022-03-31 00:00:00,,BHAGCHEM.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-88216000.0,BHAGCHEM.NS
Total Other Finance Cost,2022-03-31 00:00:00,38924000.0,BHAGCHEM.NS
Interest Expense Non Operating,2022-03-31 00:00:00,51955000.0,BHAGCHEM.NS
Interest Income Non Operating,2022-03-31 00:00:00,2663000.0,BHAGCHEM.NS
Operating Income,2022-03-31 00:00:00,596992000.0,BHAGCHEM.NS
Operating Expense,2022-03-31 00:00:00,433109000.0,BHAGCHEM.NS
Other Operating Expenses,2022-03-31 00:00:00,6992000.0,BHAGCHEM.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,87304000.0,BHAGCHEM.NS
Amortization,2022-03-31 00:00:00,1268000.0,BHAGCHEM.NS
Depreciation Income Statement,2022-03-31 00:00:00,86036000.0,BHAGCHEM.NS
Research And Development,2022-03-31 00:00:00,14374000.0,BHAGCHEM.NS
Selling General And Administration,2022-03-31 00:00:00,94479000.0,BHAGCHEM.NS
Selling And Marketing Expense,2022-03-31 00:00:00,50744000.0,BHAGCHEM.NS
General And Administrative Expense,2022-03-31 00:00:00,43735000.0,BHAGCHEM.NS
Rent And Landing Fees,2022-03-31 00:00:00,3470000.0,BHAGCHEM.NS
Gross Profit,2022-03-31 00:00:00,1030101000.0,BHAGCHEM.NS
Cost Of Revenue,2022-03-31 00:00:00,3315619000.0,BHAGCHEM.NS
Total Revenue,2022-03-31 00:00:00,4345720000.0,BHAGCHEM.NS
Operating Revenue,2022-03-31 00:00:00,4345720000.0,BHAGCHEM.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,BHAGCHEM.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,BHAGCHEM.NS
Normalized EBITDA,2021-03-31 00:00:00,,BHAGCHEM.NS
Total Unusual Items,2021-03-31 00:00:00,,BHAGCHEM.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,BHAGCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,BHAGCHEM.NS
Reconciled Depreciation,2021-03-31 00:00:00,,BHAGCHEM.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,BHAGCHEM.NS
EBITDA,2021-03-31 00:00:00,,BHAGCHEM.NS
EBIT,2021-03-31 00:00:00,,BHAGCHEM.NS
Net Interest Income,2021-03-31 00:00:00,,BHAGCHEM.NS
Interest Expense,2021-03-31 00:00:00,,BHAGCHEM.NS
Interest Income,2021-03-31 00:00:00,2541000.0,BHAGCHEM.NS
Normalized Income,2021-03-31 00:00:00,,BHAGCHEM.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,BHAGCHEM.NS
Total Expenses,2021-03-31 00:00:00,,BHAGCHEM.NS
Rent Expense Supplemental,2021-03-31 00:00:00,1800000.0,BHAGCHEM.NS
Diluted Average Shares,2021-03-31 00:00:00,,BHAGCHEM.NS
Basic Average Shares,2021-03-31 00:00:00,,BHAGCHEM.NS
Diluted EPS,2021-03-31 00:00:00,,BHAGCHEM.NS
Basic EPS,2021-03-31 00:00:00,,BHAGCHEM.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,BHAGCHEM.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,BHAGCHEM.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,BHAGCHEM.NS
Net Income,2021-03-31 00:00:00,,BHAGCHEM.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,BHAGCHEM.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,BHAGCHEM.NS
Tax Provision,2021-03-31 00:00:00,,BHAGCHEM.NS
Pretax Income,2021-03-31 00:00:00,,BHAGCHEM.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,BHAGCHEM.NS
Special Income Charges,2021-03-31 00:00:00,,BHAGCHEM.NS
Other Special Charges,2021-03-31 00:00:00,-10540000.0,BHAGCHEM.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,BHAGCHEM.NS
Total Other Finance Cost,2021-03-31 00:00:00,34230000.0,BHAGCHEM.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,BHAGCHEM.NS
Interest Income Non Operating,2021-03-31 00:00:00,2541000.0,BHAGCHEM.NS
Operating Income,2021-03-31 00:00:00,,BHAGCHEM.NS
Operating Expense,2021-03-31 00:00:00,,BHAGCHEM.NS
Other Operating Expenses,2021-03-31 00:00:00,,BHAGCHEM.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,BHAGCHEM.NS
Amortization,2021-03-31 00:00:00,1053000.0,BHAGCHEM.NS
Depreciation Income Statement,2021-03-31 00:00:00,,BHAGCHEM.NS
Research And Development,2021-03-31 00:00:00,11559000.0,BHAGCHEM.NS
Selling General And Administration,2021-03-31 00:00:00,62792000.0,BHAGCHEM.NS
Selling And Marketing Expense,2021-03-31 00:00:00,27641000.0,BHAGCHEM.NS
General And Administrative Expense,2021-03-31 00:00:00,35151000.0,BHAGCHEM.NS
Rent And Landing Fees,2021-03-31 00:00:00,1800000.0,BHAGCHEM.NS
Gross Profit,2021-03-31 00:00:00,,BHAGCHEM.NS
Cost Of Revenue,2021-03-31 00:00:00,,BHAGCHEM.NS
Total Revenue,2021-03-31 00:00:00,,BHAGCHEM.NS
Operating Revenue,2021-03-31 00:00:00,,BHAGCHEM.NS
